According to Ys Biopharma latest financial reports the cash on hand of YS is $52.18M, an increase of 36.54% to 2022. At the end of 2022 company had $38.22M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $52.18M | 36.54% |
2022 | $38.22M | 30522.25% |
2021 | $124.81K | -99.77% |
2021 | $55.05M | - |